About CD45-/CD31+/CD105+/circulating cells in patients with gynecologic malignancies-letter

Francesco Bertolini; Patrizia Mancuso; John V. Heymach

doi:10.1158/1078-0432.CCR-13-2855

About CD45^-/CD31⁺/CD105⁺/circulating cells in patients with gynecologic malignancies-letter

Francesco Bertolini, Patrizia Mancuso, John V. Heymach

Thoracic Head & Neck Medical Oncology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1393
Number of pages	1
Journal	Clinical Cancer Research
Volume	20
Issue number	5
DOIs	https://doi.org/10.1158/1078-0432.CCR-13-2855
State	Published - 2014

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/1078-0432.CCR-13-2855

Cite this

@article{c40ebb82ea3540daadeac057d68d6ff1,

title = "About CD45-/CD31+/CD105+/circulating cells in patients with gynecologic malignancies-letter",

author = "Francesco Bertolini and Patrizia Mancuso and Heymach, {John V.}",

year = "2014",

doi = "10.1158/1078-0432.CCR-13-2855",

language = "English (US)",

volume = "20",

pages = "1393",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "5",

}

TY - JOUR

T1 - About CD45-/CD31+/CD105+/circulating cells in patients with gynecologic malignancies-letter

AU - Bertolini, Francesco

AU - Mancuso, Patrizia

AU - Heymach, John V.

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84895784665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895784665&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-13-2855

DO - 10.1158/1078-0432.CCR-13-2855

M3 - Letter

C2 - 24590886

AN - SCOPUS:84895784665

SN - 1078-0432

VL - 20

SP - 1393

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 5

ER -

About CD45-/CD31+/CD105+/circulating cells in patients with gynecologic malignancies-letter

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this

About CD45^-/CD31⁺/CD105⁺/circulating cells in patients with gynecologic malignancies-letter